Metformin as a potential neuroprotective agent: Molecular mechanisms, clinical evidence and therapeutic repurposing in neurodegenerative disorders

iPharma · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles